Follow-The-Filings

Security

AVXL

Anavex Life Sciences Corp. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners 1 new 1 exit max 0.0% (Two Sigma Investments, LP)

grid → activity →
owners 7
max % 0.0%
tracked value $30M
qoq N 1 A 4 R 1 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.01 pp 1,653,696 $6M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 5,028,534 $18M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 756,792 $2M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 559,435 $2M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 419,497 $1M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 276,800 $850 hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% New 0.0% 44,856 $138 hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 278,018 $990 hist

7 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit — — —
Gross margin — — —
Net income -$47.5M -$43M -$46.38M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets — — —
Total non-current assets — — —
Total assets $154.39M $135.57M $103.82M
Total current liabilities — — —
Total non-current liabilities — — —
Total equity $141.85M $120.26M $94.87M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$27.78M -$30.81M -$39.04M
Cash from investing — — —
Cash from financing $29.65M $11.98M $9.43M
Net change in cash — — —

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders